BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12625789)

  • 1. The role of proteomics in the diagnosis and outcome prediction in colorectal cancer.
    Steinert R; Buschmann T; van der Linden M; Fels LM; Lippert H; Reymond MA
    Technol Cancer Res Treat; 2002 Aug; 1(4):297-304. PubMed ID: 12625789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC; Lin JK; Lin TC; Liang WY
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in patient management. Hereditary colorectal cancers].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Feb; 147(8):363-8. PubMed ID: 16579336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.
    Sugihara Y; Taniguchi H; Kushima R; Tsuda H; Kubota D; Ichikawa H; Sakamoto K; Nakamura Y; Tomonaga T; Fujita S; Kondo T
    J Proteomics; 2012 Sep; 75(17):5342-55. PubMed ID: 22735596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of p53 and CA19-9 prognostic molecular markers in colorectal carcinomas.
    Afrem G; Crăiţoiu S; Mărgăritescu C; Mogoantă SS
    Rom J Morphol Embryol; 2010; 51(3):473-81. PubMed ID: 20809023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional proteomics studies in colorectal cancer.
    Reymond MA; Steinert R; Kähne T; Sagynaliev E; Allal AS; Lippert H
    Pathol Res Pract; 2004; 200(2):119-27. PubMed ID: 15237920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
    Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
    Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.